- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02936362
Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals
Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals: Randomized Trial
Bread is the most common grain product in the world, with consumption surpassing 3 billion individuals per year. Sourdough whole-grain bread is considered a healthy alternative to white, refined-wheat bread.
This cross-over study will test the effect of consumption of sourdough bread compared to white bread following a short dietary intervention period (one week) on multiple clinical parameters and gut microbiota.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rehovot, Israel
- Weizmann Institute of Science
-
Tel Aviv, Israel, 64239
- Department of Gastroentherology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Able to provide and signed informed consent form
- Over 18 years
- Not in active military service
- Ability to technically operate a glucometer
Exclusion Criteria:
- Prediagnosed type I / type II diabetes mellitus
- Pregnancy
- Usage of antibiotics within three months prior to participation
- Chronically active inflammatory or neoplastic disease in the three years prior to enrollment
- Skin disease, including contact dermatitis, precluding proper attachment of the continuous glucose monitor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Sourdough bread, white bread
Consumption of sourdough bread for one week, 2 week washout, consumption of white bread for one week
|
Participants will be given sourdough bread to consume instead of other wheat products.
145g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)
Participants will be given white bread to consume instead of other wheat products.
110g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)
|
|
Other: White bread, sourdough bread
Consumption of white bread for one week, 2 week washout, consumption of sourdough bread for one week
|
Participants will be given sourdough bread to consume instead of other wheat products.
145g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)
Participants will be given white bread to consume instead of other wheat products.
110g will be consumed every morning in addition to ad libitum consumption throughout the day (matched between first and second intervention periods)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes to glycemic control
Time Frame: One week
|
Measured as response to an Oral Glucose Tolerance Test (OGTT; mg/dl*h).
|
One week
|
|
Changes to glycemic control
Time Frame: One week
|
Measured as blood glucose levels at wake-up (mg/dl).
|
One week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes to total cholesterol levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to HDL cholesterol levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to LDL cholesterol levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to triglycerides levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to C-Reactive Protein (CRP) levels (mg/l)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to weight (Kg.)
Time Frame: One week
|
One week
|
|
|
Changes to Basal Metabolic Rate (BMR; J)
Time Frame: One week
|
One week
|
|
|
Changes to blood pressure (mmHg)
Time Frame: One week
|
One week
|
|
|
Changes to Alanine Transaminase (ALT) levels (IU/l)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Aspartate Transaminase (AST) levels (IU/I)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Gamma-Glutamyl Transpeptidase (GGT) levels (IU/l)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Creatinine levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Magnesium levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Calcium levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Iron levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Urea levels (mg/dl)
Time Frame: One week
|
Measured by a blood test.
|
One week
|
|
Changes to Lactate Dehydrogenase (LDH) levels
Time Frame: One week
|
Measured by a blood test (IU/l)
|
One week
|
|
Changes to Thyroid Stimulating Hormone (TSH)
Time Frame: One week D
|
Measured by a blood test (mIU/ml)
|
One week D
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes to gut microbiome composition and function
Time Frame: One week
|
Measured by metagenomic sequencing
|
One week
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TASMC-12-ZH-658A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Weight Changes
-
Pusan National University HospitalCompletedWeight Change, Body
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
Chiang Mai UniversityCompleted
-
Washington University School of MedicineCompleted
-
Washington University School of MedicineCompletedWeight ChangeUnited States
-
Hacettepe UniversityCompleted
-
University Hospital Center of MartiniqueRecruiting
-
Huashan HospitalNot yet recruitingWeight Change, BodyChina
-
University of PittsburghTerminatedWeight Loss | Motor ActivityUnited States
-
Instituto de Investigación Hospital Universitario...CompletedObesity | Overweight | Weight Loss | Body Weight Changes | Weight Change, BodySpain
Clinical Trials on Consumption of sourdough bread
-
Arizona State UniversityCompletedInsulin ResistanceUnited States
-
KU LeuvenCompletedAppetite Regulation | Energy IntakeBelgium
-
Oy Karl Fazer AbCompletedIrritable Bowel Syndrome | Wheat SensitivityFinland
-
Chalmers University of TechnologySahlgrenska University Hospital, SwedenCompletedAnaemia | Iron Bioavailability
-
Ege UniversityCompletedObesity | Glycemic Index | Blood Glucose | BreadTurkey
-
Swedish University of Agricultural SciencesUppsala UniversityCompleted
-
Ege UniversityCompletedObesity | Celiac Disease | Blood Glucose | Flour SensitivityTurkey
-
University of UdineWageningen University and ResearchCompletedGlycemic Index | Oral Processing | Glucose Response | Insulin ResponseItaly
-
KU LeuvenCompletedGastric Emptying | Energy Intake | Satiety | Appetite | Glucose Response | Insulin ResponseBelgium
-
TNONederlands Bakkerij Centrum; PepsiCo, Inc.Completed